CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

ReproSource has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top Regenerative Medicine Solution Provider 2026,” based on our proprietary methodology, reflecting its position in the industry, and is also named among “,” reflecting its broader leadership. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with , .

ReproSource
Removing Barriers to Wellness and Male Fertility

ReproSource

Charles Jenkins, ReproSource | Life Science Review | Top Regenerative Medicine Solution ProviderCharles Jenkins, Product Director
Male fertility is an often-overlooked area of reproductive wellness, even though roughly half of all reproductive challenges stem from male factors.

One test available to evaluate male fertility is a semen analysis, which measures factors such as sperm concentration, motility (movement), morphology (shape) and viability. Unfortunately, many men face real barriers to completing a semen analysis, including discomfort, stigma, or the practical challenges of scheduling and visiting a collection site. A mail-in semen analysis option, offered by select laboratories, helps remove many of those barriers. By allowing men to provide a specimen privately and conveniently, on their own time, it becomes easier to complete a timely fertility evaluation. This expands access, modernizes reproductive testing and supports both partners throughout the fertility journey. Improved compliance can also reduce delays in diagnosis and help couples begin fertility evaluation and treatment sooner.

How Mail-In Test Services Work

One of the biggest challenges with most at-home collection options is specimen stability. With traditional collection methods, semen specimens were historically stable for only about one hour after collection. As a result, men often needed to provide a specimen in a controlled healthcare setting, such as a busy doctor’s office, an environment where many understandably may not feel comfortable.

In recent years, however, innovations in laboratory processing have extended specimen stability. Men can now collect specimens at home, while testing laboratories are able to provide semen analysis results that are clinically comparable to those generated through traditional in-office collection methods. A patient interested in this testing first discusses the option with a clinician. Once the clinician orders the test, the patient receives the necessary collection and preservation supplies by mail. The patient then collects and ships the specimen using a temperature-controlled and monitored shipping container with a prepaid shipping label.

In a double-blind study, results demonstrated accurate and comprehensive semen analysis from specimens collected remotely and shipped overnight. Measures such as total motility, concentration and morphology remained highly consistent between 1-hour and 26-hour analyses. These findings indicate that delayed semen analysis on mailed-in specimens can yield results consistent with those from 1-hour analysis, improving access to male fertility diagnostics through an at-home collection option.

Expanding Semen Analysis to Include Other Indicators of Health

Semen analysis is also evolving to include a broader range of biomarkers, as emerging research demonstrates the potential value of semen testing in providing a more comprehensive picture of men’s overall wellness. Abnormal semen parameters have been linked to serious health conditions, including increased risks of chronic diseases such as Type 2 Diabetes, as well as mortality and certain cancers. As a result, more physicians and patients have become interested in monitoring sperm health more closely.

  • Many men face real barriers to completing a semen analysis, including discomfort, stigma and the practical challenges of scheduling and visiting a collection site.


Over the last several years, patients have also expressed growing interest in at-home service options and greater convenience in how they access testing. Exploring ways to remove barriers to testing is incredibly important in empowering people with insights that make managing health more proactive, connected and personal. When testing solutions are designed to meet patients where they are, innovation can make a meaningful difference. Reducing stigma and eliminating barriers to semen analysis means more men can access the answers they need to continue their fertility and wellness journeys.

Top Regenerative Medicine Solution Provider 2026
Current Issue

Company : ReproSource

Management
Charles Jenkins, Product Director

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://regenerative-medicine.lifesciencesreview.com/vendor/semen-analysis-testing-removing-barriers-to-wellness-and-male-fertility-cid-2427-mid-379.html